Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» solid tumors
solid tumors
AbbVie ends stay with the ADAM family, dropping MacroGenics-partnered ADC in light of early data
Fierce Biotech
Fri, 03/8/24 - 11:07 am
AbbVie
IMGC936
ADAM9
solid tumors
Macrogenics
Janux shares triple on early cancer immunotherapy data
BioPharma Dive
Wed, 02/28/24 - 11:08 am
Janux Therapeutics
clinical trials
solid tumors
prostate cancer
T-cell engager
6 first-half 2024 oncology data readouts to watch
BioSpace
Mon, 02/26/24 - 11:20 am
oncology
clinical trials
Daiichi Sankyo
AstraZeneca
Enhertu
metastatic breast cancer
Gilead Sciences
Trodelvy
bladder cancer
GSK
Zejula
Jemperli
ovarian cancer
Roche
tiragolumab
Tecentriq
non-small cell lung cancer
Cue Biopharma
CUE-101
head and neck cancer
Elicio Therapeutics
ELI-002
solid tumors
FDA approves Iovance's Amtagvi as first T-cell therapy for a solid tumor
Fierce Pharma
Sun, 02/18/24 - 08:39 pm
Iovance
FDA
Amtagvi
solid tumors
t-cell therapies
cell therapy
Gilead Sciences pauses enrollment for cancer treatment in solid tumor trials
Reuters
Thu, 02/15/24 - 07:14 pm
Gilead Sciences
magrolimab
solid tumors
Roche dumps Repare's synthetic lethal drug days after making $40M stitch in Tapistry trial
Fierce Biotech
Tue, 02/13/24 - 11:29 am
Roche
Repare Therapeutics
solid tumors
clinical trials
synthetic lethality
Gilead downloads solid tumor program from Compugen for $60M upfront
Fierce Biotech
Tue, 12/19/23 - 10:05 am
Gilead Sciences
CompuGen
solid tumors
Pfizer Inks Potential $1B ADC Deal with Nona, Closes Seagen Acquisition
BioSpace
Fri, 12/15/23 - 11:35 am
Pfizer
Nona Biosciences
M&A
Seagen
solid tumors
FDA starts speedy review of Amgen’s lung cancer BiTE therapy
Pharmaphorum
Thu, 12/14/23 - 09:34 am
Amgen
tarlatamab
small cell lung cancer
bispecifics
BiTE
solid tumors
Novartis pays Legend $100M upfront to give solid tumor CAR-T the T-Charge treatment
Fierce Biotech
Mon, 11/13/23 - 11:55 am
Novartis
Legend Biotech
CAR-T
T-Charge
solid tumors
Merck KGaA pays $169M for selective PARP1 drug, stepping up challenge to AstraZeneca and Gilead
Fierce Biotech
Mon, 10/30/23 - 11:58 am
Merck KGaA
PARP inhibitors
Lynparza
Zejula
AstraZeneca
Gilead Sciences
solid tumors
Roche drops oral eye disease drug after completing phase 2, pulls back from solid tumor bispecific
Fierce Biotech
Thu, 10/19/23 - 11:36 am
Roche
diabetic retinopathy
solid tumors
bispecific antibodies
Adlai Nortye IPO gives old Novartis cancer drug new life
BioPharma Dive
Fri, 09/29/23 - 10:22 am
Adlai Nortye
IPOs
Novartis
AN2025
head and neck cancer
solid tumors
1ST Biotherapeutics and Merck to assess cancer combination treatment
Clinical Trials Arena
Wed, 09/20/23 - 11:09 pm
Merck
1st Biotherapeutics
Keytruda
solid tumors
clinical trials
FDA grants clearance to Harbour’s IND for solid tumors therapy trial
Clinical Trials Arena
Mon, 08/28/23 - 11:58 am
Harbour BioMed
clinical trials
HBM9033
solid tumors
Roche’s Divarasib Scores Phase I Win in KRAS-Mutated Solid Tumors
BioSpace
Thu, 08/24/23 - 11:50 am
Roche
Genentech
divarasib
KRAS inhibitors
solid tumors
clinical trials
Moderna, CARsgen Join Forces Combining mRNA Cancer Vaccine with CAR T
BioSpace
Mon, 08/21/23 - 08:00 pm
Moderna Therapeutics
CARsgen
MRNA
cancer
cancer vaccine
vaccines
solid tumors
CAR-T
Moderna reveals Claudin18.2 ambitions via cancer vaccine, solid tumor CAR-T combo plans
Fierce Biotech
Mon, 08/21/23 - 10:05 am
Moderna Therapeutics
Claudin18.2
MRNA
vaccines
CAR-T
cancer vaccine
solid tumors
Bio-Thera reports positive data from solid tumors therapy trial
Clinical Trials Arena
Mon, 08/14/23 - 10:11 am
Bio-Thera Solutions
solid tumors
clinical trials
BAT8006
FDA clears Qualigen’s IND for trial of solid tumour therapy
Clinical Trials Arena
Wed, 08/2/23 - 10:20 am
Qualigen Therapeutics
clinical trials
solid tumors
QN-302
Pages
1
2
3
4
5
6
7
8
9
next ›
last »